Caspase-3 Levels Alter With Non-surgical Periodontal Therapy in Patients With Periodontitis.

Abstract

Background This study aims to evaluate the levels of caspase-3 in the gingival crevicular fluid (GCF) of chronic periodontitis patients before and after phase I treatment and compare it with those of healthy controls. Methodology The study involved 40 participants who were divided into two groups. Group 1 consisted of 30 chronic periodontitis patients, and group 2 consisted of 10 healthy controls. GCF was collected at baseline for both groups and at three months for group 1. Periodontal parameters and caspase-3 levels were analyzed before and after non-surgical therapy. Results Caspase-3 levels were higher in patients with chronic periodontitis compared with healthy controls. However, comparing baseline and postoperative levels, there was a statistically significant reduction in periodontal parameters and caspase-3 levels, with 0.80 ± 0.03 at baseline and 0.44 ± 0.02 at three months after non-surgical periodontal therapy. Conclusions Caspase-3, being the key molecule in apoptosis, was found to be at lower concentrations in healthy gingiva and was increased in the presence of periodontal disease. However, with non-surgical periodontal therapy, caspase-3 levels decreased, proving that non-surgical periodontal therapy affects host immune mechanisms and reduces apoptosis, thereby preventing disease progression.